Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Am Surg. 2020 Dec 28;88(1):83–92. doi: 10.1177/0003134820973739

Table 2.

Characteristics of Patients Undergoing Liver Resection by Readmission Status.

All patients
Not readmitted
readmitted
Characteristic N = 8635 N = 8132 N = 503 P-value
Age in years, median (IQR) 64.0 (55.0, 73.0) 64.0 (55.0, 73.0) 62.0 (53.0, 72.0) .020
Sex, N (%)
 Male 5929 (68.7) 5569 (68.5) 360 (71.6) .15
 Female 2706 (31.3) 2563 (31.5) 143 (28.4)
Race, N(%)
 White 5525 (64.0) 5210 (64.1) 315 (62.6) .54
 African American 1159 (13.4) 1094 (13.5) 65 (12.9)
 Asian/PI 1099 (12.7) 1037 (12.8) 62 (12.3)
 Hispanic 567 (6.6) 527 (6.5) 40 (8.0)
 Other/unknown 285 (3.3) 264 (3.2) 21 (4.2)
Insurance type, N(%)
 Private 3469 (40.2) 3256 (40.0) 213 (42.3) .093
 Medicaid 746 (8.6) 693 (8.5) 53 (10.5)
 Medicare 3807 (44.1) 3600 (44.3) 207 (41.2)
 Not insured 368 (4.3) 345 (4.2) 23 (4.6)
 Other/unknown 245 (2.8) 238 (2.9) 7 (1.4)
Income ($USD), N(%)
 <$38 000 1710 (19.8) 1610 (19.8) 100 (19.9) .92
 $38 000-$47 999 2044 (23.7) 1931 (23.7) 113 (22.5)
 $48 000-$62 999 2323 (26.9) 2183 (26.8) 140 (27.8)
 >$63k 2558 (29.6) 2408 (29.6) 150 (29.8)
No HS diploma, N(%)
 21%+ 1842 (21.3) 1741 (21.4) 101 (20.1) .19
 13-20.9% 2330 (27.0) 2175 (26.7) 155 (30.8)
 7-12.9% 2606 (30.2) 2455 (30.2) 151 (30.0)
 <7% 1857 (21.5) 1761 (21.7) 96 (19.1)
Patient urban/rural location, N(%)
 Metro areas 7440 (86.2) 6999 (86.1) 441 (87.7) .57
 Metro-adjacent 755 (8.7) 717 (8.8) 38 (7.6)
 Not Metro-adjacent 314 (3.6) 299 (3.7) 15 (3.0)
 Rural 126 (1.5) 117 (1.4) 9 (1.8)
Miles to hospital, median (IQR) 14.8 (5.8, 47.3) 15.0 (5.8, 47.5) 13.2 (6.2, 41.2) .19
Tumor size, N(%)
 <2 cm 657 (7.6) 605 (7.4) 52 (10.3) .11
 2-5 cm 2979 (34.5) 2812 (34.6) 167 (33.2)
 >5 cm 4655 (53.9) 4388 (54.0) 267 (53.1)
 Unknown 344 (4.0) 327 (4.0) 17 (3.4)
Postoperative length of stay (days), median (IQR) 6.0 (4.0, 9.0) 7.0 (5.0, 11.0) <.001
AJCC cancer stage, N(%)
 Stage I 3553 (41.1) 3378 (41.5) 175 (34.8) .025
 Stage II 2058 (23.8) 1922 (23.6) 136 (27.0)
 Stage III 1819 (21.1) 1695 (20.8) 124 (24.7)
 Stage IV 302 (3.5) 283 (3.5) 19 (3.8)
 Unknown 903 (10.5) 854 (10.5) 49 (9.7)
Charlson-Deyo score, N(%)
 0 4668 (54.1) 4434 (54.5) 234 (46.5) .002
 1 2522 (29.2) 2352 (28.9) 170 (33.8)
 2 1445 (16.7) 1346 (16.6) 99 (19.7)
Hospital type, N(%)
 Community 2854 (33.1) 2710 (32.3) 144 (28.6) .087
 Academic 5781 (66.9) 5422 (67.7) 359 (71.4)
Facility location, N(%)
 New England 408 (4.7) 384 (4.7) 24 (4.8) <.001
 Middle Atlantic 1509 (17.5) 1380 (17.0) 129 (25.6)
 South Atlantic 1671 (19.4) 1569 (19.3) 102 (20.3)
 East North Central 1391 (16.1) 1330 (16.4) 61 (12.1)
 East South Central 588 (6.8) 555 (6.8) 33 (6.6)
 West North Central 647 (7.5) 614 (7.6) 33 (6.6)
 West South Central 861 (10.0) 808 (9.9) 53 (10.5)
 Mountain 330 (3.8) 303 (3.7) 27 (5.4)
 Pacific 1230 (14.2) 1189 (14.6) 41 (8.2)
Nodes resected, N(%) 1585 (18.4) 6657 (81.9) 393 (78.1) .036
Care transitions, N(%)
 Yes 5204 (60.3) 4885 (60.1) 319 (63.4) .14
 No 3431 (39.7) 3247 (39.9) 184 (36.6)
Surgery type
 Wedge/segmental 4630 (53.6) 4379 (53.8) 251 (49.9) .36
 Lobectomy 2470 (28.6) 2318 (28.5) 152 (30.2)
 Extended lobectomy 613 (7.1) 572 (7.0) 41 (8.2)
 Unknown 922 (10.7) 863 (10.6) 59 (11.7)

Abbreviations: AJCC, American Joint Committee on Cancer.